[HTML][HTML] The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort

G Gouya, G Sturm, C Lamina, E Zitt, O Freistätter… - PLoS …, 2011 - journals.plos.org
High levels of the plasma peptides mid-regional pro-adrenomedullin (MR-proADM) and mid-
regional pro-atrial natriuretic peptide (MR-proANP) are associated with clinical outcomes in …

[HTML][HTML] Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study

B Dieplinger, T Mueller, B Kollerits, J Struck, E Ritz… - Kidney international, 2009 - Elsevier
A-type natriuretic peptide (ANP) and adrenomedullin (ADM) are potent hypotensive, diuretic,
and natriuretic peptides involved in maintaining cardiovascular and renal homeostasis. We …

Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals

SS Bhandari, JE Davies, J Struck, LL Ng - Biomarkers, 2011 - Taylor & Francis
Background: MRproADM and MRproANP can be used as diagnostic and prognostic
markers in heart failure. Aim: The objective was to identify confounding factors for the …

Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease

F Yoshihara, A Ernst, NG Morgenthaler… - Nephrology Dialysis …, 2007 - academic.oup.com
Background. Although adrenomedullin is an indicator of cardiac dysfunction in
haemodialysis patients, the clinical significance of midregional proadrenomedullin has not …

Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population

FP Brouwers, RA de Boer, P van der Harst, J Struck… - Heart, 2012 - heart.bmj.com
Objective Experimental studies have shown that adrenomedullin (ADM) has an important
role in circulatory homeostasis. Mid-regional pro-ADM (MR-proADM) is a stable form of …

[HTML][HTML] Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up—Data from FAR …

M Špinarová, J Špinar, L Špinarová, J Krejčí… - Medicina, 2022 - mdpi.com
Background and Objectives: The aim of this paper is to evaluate the impact of humoral
substance mid-regional pro-adrenomedullin (MR-proADM) on the two-year survival of …

[HTML][HTML] Mid-regional proadrenomedullin as a new biomarker of kidney and cardiovascular diseases—is it the future?

K Czajkowska, E Zbroch, A Bielach-Bazyluk… - Journal of Clinical …, 2021 - mdpi.com
The increasing prevalence of cardiovascular disease and concomitant chronic kidney
disease among the aging populations is responsible for considerable growth of mortality …

Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based …

A Funke-Kaiser, AS Havulinna, T Zeller… - Annals of …, 2014 - Taylor & Francis
Introduction. To examine whether midregional pro-adrenomedullin (MR-proADM) plasma
concentrations predict incident cardiovascular outcomes in the general population …

Mid‐region pro‐adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long‐term mortality in stable outpatients with heart failure

Y Xue, P Taub, N Iqbal, A Fard… - European journal of …, 2013 - Wiley Online Library
Aims The aim of this study was to evaluate the long‐term prognostic utility of mid‐region
prohormone adrenomedullin (MR‐proADM) in stable outpatients with heart failure (HF) …

Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community

KM Eggers, P Venge, B Lindahl, L Lind - International journal of cardiology, 2013 - Elsevier
Background The mid-regional part of the prohormone of adrenomedullin (MR-proADM) is
emerging as a novel risk indicator in patients with cardiac disease. We investigated MR …